
Future Prospects
As per WTO, from the year 2005, India will grant product patent
recognition to all new chemical entities (NCEs) i.e., bulk drugs
developed then onwards. The Indian Government's decision to allow
100 percent foreign direct investment into the drugs and
pharmaceutical industry is expected to aid the growth of contract
research in the country. Technology transfer to 100 percent Indian
subsidiaries of MNCs is expected only in 2005.
Indian pharmaceutical interests in making a mark on the global
scene got a boost when Dr. Reddy's licensed two of its anti-diabetic
molecules to Novo Nordisk and when Ranbaxy licensed its Novel Drug
Delivery System (NDDS) of ciprofloxacin to Bayer. MNCs in India
faced the problem of having a very high DPCO coverage, weakening
their bottom lines as well as hindering their growth through the
launch of new products. DPCO coverage is expected to be diluted
further in the near future benefiting the MNCs. New legislation is
also expected in the OTC segment increasing the number of brands in
the Over the Counter (OTC) segment.
The Indian pharmaceutical industry is also getting increasingly
U.S. FDA compliant to harness the growth opportunities in areas of
contract manufacturing and research. Indian companies such as
Ranbaxy, Sun Pharma, and Dr. Reddy's are increasingly focusing on
tapping the U.S. generic market, projected to be around $18 billion
by 2004.


DOWNLOAD
PDF PRODUCT RANGE DETAILS

 The
portal gives you extensive list of the manufacturer of drug and
pharmaceutical manufacturers. It also contains the valuable information
pertaining to the drug manufacturing with the names of various drugs.
 Pharmaceutical
Finished Formulations:
Under finished pharmaceutical formulations the drugs are manufactured
under strict quality control for ensuring a completely safe product. The
finished formulations are available in the form of tablets, capsules, injections.
 Pharmaceutical
Drugs:
Pharmaceutical Drugs are those drugs that are given under the
supervision of physicians to cure various physical disorders. They are
either prescriptive or non prescriptive.
|
CONTACT US WITH YOUR HEALTHCARE PRODUCTS REQUIREMENTS FOR CUSTOM MANUFACTURING AND ESSENTIAL MEDICINE SUPPLIES FOR YOUR COUNTRY. DISTRIBUTORS, RETAILERS, WHOLESALERS, PHARMACY AND IMPORTERS.
|
 |
|
|